Soutenir la recherche

Publications et ressources

Trier par :
Afficher :
91-100 sur 397

Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy

N De'Angelis, S Abdalla, V Lizzi, F Esposito, P Genova, L Roy, F Galacteros, Alain LUCIANI, F Brunetti,

Surgery. 01/12/2017;162(6) : 1219-1230 10.1016/j.surg.2017.07.016 14/09/2017

Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains

Frédéric LE GAL, Ségolène BRICHLER, T Drugan, C Alloui, D Roulot, Jean-Michel PAWLOTSKY, P Deny, Emmanuel GORDIEN,

Hepatology. 01/12/2017;66(6) : 1826-1841 10.1002/hep.29574. 30/10/2017

Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis

C Lim, H Shinkawa, K Hasegawa, P Bhangui, C Salloum, C Gomez Gavara, E Lahat, K Omichi, J Arita, Y Sakamoto, P Compagnon, Cyrille FERAY, N Kokudo, D Azoulay,

Liver Transpl. 01/12/2017;23(12) : 1553-1563 10.1002/lt.24952.

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial

M Bazinet, V Pantea, V Cebotarescu, L Cojuhari, P Jimbei, JK Albrecht, P Schmid, Frédéric LE GAL, Emmanuel GORDIEN, A Krawczyk, H Mijocevic, H Karimzadeh, M Roggendorf, A Vaillant,

Lancet Gastroenterol hepatol. 01/12/2017;2(12) : 877-889 10.1016/S2468-1253(17)30288-1. 28/09/2017

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

AD Marshall, EB Cunningham, S Nielsen, A Aghemo, H Alho, M Backmund, P Bruggmann, O Dalgard, C Seguin-Devaux, R Flisiak, GR Foster, L Gheorge, D Goldberg, I Goulis, M Hickman, P Hoffmann, L Janconriene, P Jarcuska, M Kaberg, LG Kostrikis, M Makara, M Maimets, RT Marinho, M Maticic, S Norris, S Olafsson, A Ovrehus, Jean-Michel PAWLOTSKY, J Pocock, G Robayes, C Roncero, M Simonova, J Sperl, M Tait, I Tolmane, S Tomaselli, M van der Valk, A Vince, GJ Dore, JV Lazarus, J Grebely, International Network on Hepatitis in Substance Users (INHSU)

Lancet Gastroenterol Hepatol. 27/11/2017;pii: S2468-1253(17) : 30284-4 0.1016/S2468-1253(17)30284-4. 27/11/2017

Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with HCV genotype 2, 4, 5, or 6 infection: the C-SCAPE study

A Brown, Christophe HEZODE, E Zuckerman, GR Foster, A Zekry, SK Roberts, F Lahser, C Durkan, C Badshah, B Zhang, M Robertson, J Wahl, E Barr, B Haber, C-SCAPE Study Investigators

J Viral Hepat. 20/11/2017;25(5) : 457-464 10.1111/jvh.12801 14/03/2018

Three-dimensional Image Fusion Guidance for Transjugular Intrahepatic Portosystemic Shunt Placement

Vania TACHER, A Petit, H Derbel, L Novelli, M Vitellius, Alain LUCIANI, A Rahmouni, C Duvoux, C Salloum, M Chiaradia, H Kobeiter,

Cardiovasc Intervent Radiol. 01/11/2017;40(11) : 1732-1739 10.1007/s00270-017-1699-9 17/05/2017

Minor laparoscopic liver resection: toward 1-day surgery?

N De'Angelis, B Menahem, P Compagnon, JC Merle, F Brunetti, Alain LUCIANI, D Cherqui, A Laurent,

Surg Endosc. 01/11/2017;31(11) : 4458-4465 10.1007/s00464-017-5498-9. 04/04/2017

Response to Cytoplasmic rods and rings in ribavirin and Cytoplasmic rods and rings in mycophenolic acid treatment

JJ Feld, Jean-Michel PAWLOTSKY, F Tatsch, M Sulkowski, F Poordad, I Jacobson,

Liver Int. 01/11/2017;37(11) : 1743-1744 10.1111/liv.13567.

Afficher :
91-100 sur 397